Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorRigshospitalet, Denmark
About this trial
a randomized, investigator-blind, interventinal study will compare the effect of benzalkonium-chloride (BAK) preserved and preservative-free (PF) eye drops on conjunctival goblet cells.
Eligibility criteria
Qualifiers
Age >18years
Danish speaking
Open angle glaucoma or ocular hypertension
Average intraocular pressure equal to or above 22 mmHg
Disqualifiers
None
Trial design
Treatments tested in this trial
- Xalatan
- Monoprost
Treatment groups
28 Participants
are divided into 2 treatment groupsSponsors and collaborators
Rigshospitalet, Denmark
Lead sponsor
Laboratoires Thea
Collaborator
Source ClinicalTrials.gov